Euryale
Euryale is a French regulated portfolio management company (société de gestion de portefeuille) that manages SCPI funds dedicated exclusively to healthcare real estate across 9 countries, serving retail savers, wealth professionals, institutional investors, and healthcare facility operators with €3.3B+ in capitalization.
- Company typePrivate
- Founded2010
- HeadquartersNot specified, France
- Headcount51–100
- GTM typeB2B and B2C
- OfferingServices
What Euryale does
Euryale is a French regulated portfolio management company (société de gestion de portefeuille) founded around 2010 and headquartered in Paris, operating under the holding Groupe Patrimoines de France. It specializes exclusively in healthcare real estate, managing a portfolio of SCPI (Société Civile de Placement Immobilier) vehicles — including Pierval Santé (open international healthcare SCPI), Euryale Horizons Santé (newly launched), Trajectoire Santé (professional-only), and the now-closed Pierval residential SCPI — with combined capitalization exceeding €3.3 billion across 9 countries. The company adopted Société à Mission status in 2025, with the mission independently audited under the French Pacte Law.
The firm generates revenue primarily through recurring asset management fees charged on its SCPI capitalization, supplemented by subscription commissions on new investor flows. Distribution combines a self-serve online extranet for retail savers, a wealth-management professional channel for advised retail, and dedicated institutional investor relationship management. Euryale also provides sale-leaseback and development-financing solutions to healthcare facility operators — spanning senior living, hospitals, and medical offices — through long-dated triple-net leases (e.g., 12-year leases with Elsan, 25-year leases with Excelsoins). The asset base is actively managed, with notable single-asset transactions including the €152M Hôpital Privé de Moselle acquisition in 2023 and a €20M first Canadian asset that year.
Euryale serves four distinct customer segments: individual savers seeking long-term income with societal impact, wealth professionals distributing the products, institutional investors pursuing diversified healthcare real estate exposure, and healthcare facility operators partnering for real estate financing. Performance metrics include a 4.06% distribution rate and 4.24% since-inception TRI for the flagship Pierval Santé, with newer vehicles targeting 5.50% annual distributions. The firm positions itself as a first-mover and one of the European leaders in dedicated healthcare real estate investment.
Euryale firmographics
Firmographics- Name
- Euryale
- Legal name
- Euryale Asset Management
- Website
- https://euryale.com
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Euryale is a French regulated portfolio management company (société de gestion de portefeuille) that manages SCPI funds dedicated exclusively to healthcare real estate across 9 countries, serving retail savers, wealth professionals, institutional investors, and healthcare facility operators with €3.3B+ in capitalization.
- Ownership category
- akta.pro rank
Euryale industry classification
Industry- Product category
- Healthcare Real Estate Asset Management
- NAICS
- Portfolio Management and Investment Advice (523940), Portfolio Management and Investment Advice (52394), Funds, Trusts, and Other Financial Vehicles (525)
- SIC
- Investment Advice (6282), Investors, Nec (6799)
- akta.pro primary industry
- Special Purpose & Alternative Asset Brokerage (BPAJABAH)
- akta.pro secondary industry
- Family Office Advisory & Outsourced CIO (OCIO) (FSAAADAC)
Keywords
Where Euryale is headquartered
LocationHeadquarters
- HQ city
- Not specified
- HQ country
- France
- HQ region
- Europe
Offices1 record
Markets served
Euryale business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- SCPI Asset Management Fees: Euryale generates revenue through asset management fees charged on the assets under management across its SCPI funds. As a société de gestion de portefeuille, the firm earns recurring management fees based on the capitalisation of its funds. With a capitalisation exceeding €3.3 billion, management fees constitute the primary revenue stream.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Annual | Pierval Santé – open for subscription, €204 per share, minimum subscription €1,020 (5 shares) |
| Unit Pricing | Annual | Euryale Horizons Santé – new product, €50 per share, minimum subscription €1,000 (20 shares) |
| Unit Pricing | Annual | Trajectoire Santé – reserved for professional clients, net performance 2.83% in 2025, 12.72% since inception |
| Unit Pricing | Annual | Pierval – closed to subscription, €1,250 per share, minimum subscription €6,250 (5 shares) |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
Euryale product offering
Product offeringCore offering
Euryale is a French société de gestion de portefeuille (portfolio management company) that manages SCPI (Société Civile de Placement Immobilier) real estate investment vehicles dedicated 100% to healthcare real estate across 9 countries. It offers four SCPI funds — Pierval Santé (open international healthcare), Euryale Horizons Santé (new international healthcare), Trajectoire Santé (professional-only international healthcare), and Pierval (closed French residential) — to individual savers, institutional investors, wealth management professionals, and healthcare facility operators.
Product overview
Euryale offers a portfolio of SCPI (Société Civile de Placement Immobilier) products specializing in healthcare real estate. The core offering comprises four named SCPI products: Pierval Santé (open international healthcare SCPI), Euryale Horizons Santé (new international healthcare SCPI), Trajectoire Santé (professional-only international healthcare SCPI), and Pierval (closed French residential SCPI). All products are underwritten by the same asset management platform and share Euryale's ESG-focused investment strategy in healthcare infrastructure.
Differentiator
Problem solved
Functional benefit
Products and services
- Pierval Santé Open-to-subscription international healthcare SCPI (real estate investment trust) with a TRI of 4.24% since inception, a 2025 distribution rate of 4.06%, a share price of €204, and a minimum subscription of €1,020 (5 shares). Designed for individual and institutional investors seeking long-term exposure to healthcare real estate across 9 countries.
- Euryale Horizons Santé Newly launched international healthcare SCPI targeting a 5.50% annual distribution rate and 5.50% target PGA over 10 years (non-guaranteed), with a share price of €50 and minimum subscription of €1,000. Targeted at investors seeking higher targeted yields and capital appreciation over a 10-year horizon.
- Trajectoire Santé International healthcare SCPI reserved exclusively for professional clients, achieving 2.83% net performance in 2025 and 12.72% since inception. Accessible only through life insurance (assurance vie), capitalisation, or PER (pension savings) unit-linked accounts.
- Pierval French residential BBC (low-energy building) SCPI closed to new subscriptions, with a share price of €1,250 and minimum subscription of €6,250. Held for legacy investors, no longer accepting new capital.
Quantifiable outcome
- TRI of 4.24% since inception for Pierval Santé SCPI
- +5 more outcomes
Companies that use Euryale
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles4 records
Euryale technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Euryale partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Euryale ServicesminorEuryale Services (euryale-services.fr) is a related entity providing services associated with the Euryale group, listed in the footer of the website.
Scale indicators4 records
Recent moves5 records
Expansion highlights5 records
Euryale competitors and assessment
Company assessmentDirect peers
- Sofidy: Leading French asset manager specializing in SCPI and real estate investment solutions for retail savers. Direct competitor in the French SCPI distribution market with overlapping product offerings.
- Perial Asset Management: Major French SCPI manager offering diversified and thematic real estate funds including healthcare/senior living strategies. Comparable product platform and retail distribution model to Euryale.
- Primonial REIM: One of the largest French SCPI/REIT managers with significant healthcare and senior-living exposure. Direct competitor in distributing healthcare real estate investment vehicles to retail and institutional investors in France.
- Paref Gestion: French SCPI manager with healthcare-adjacent real estate strategies and similar target customer base of retail savers and wealth advisors. Comparable fund structure and distribution approach.
- Inter Gestion REIM: French SCPI manager distributing real estate investment products to retail investors via wealth management advisors. Comparable distribution model and target retail saver segment to Euryale.
Broad incumbents
- AXA IM Alts: Large European real estate asset manager with healthcare and senior living strategies among its alternatives platform. Much larger incumbent with broader mandate but overlapping healthcare RE thesis.
- Welltower Inc. Major US healthcare REIT focused on senior housing and medical office real estate. Operates at massive scale in the same healthcare real estate vertical as Euryale, serving institutional capital globally.
- Swiss Life Asset Managers (Healthcare): European asset manager with significant healthcare real estate exposure through its open-ended real estate funds. Operates at much larger scale with broader product range but competes in healthcare RE allocation.
- Medical Properties Trust: US-listed REIT focused on healthcare facility real estate. Operates in same healthcare real estate investment thesis globally, though structured as a public REIT rather than private SCPI manager.
Emerging players
- Alderan: French asset manager focused on operational real estate including healthcare and senior living. Smaller and more recent entrant than Euryale but competes in the same niche SCPI/healthcare RE category.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks4 records
Key highlights7 records
Customer concentration
Euryale social profiles
Digital presenceEuryale compliance and trust
Trust signalCompliance1 record
Euryale financial estimates
Financial estimateRevenue estimate
Valuation estimate
Euryale leadership team
Management profileNumber of profiles
Euryale subsidiaries and ownership
Company hierarchySubsidiaries2 records
Euryale funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Euryale M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Euryale
What does Euryale do?
Euryale is a French société de gestion de portefeuille (portfolio management company) that manages SCPI (Société Civile de Placement Immobilier) real estate investment vehicles dedicated 100% to healthcare real estate across 9 countries. It offers four SCPI funds — Pierval Santé (open international healthcare), Euryale Horizons Santé (new international healthcare), Trajectoire Santé (professional-only international healthcare), and Pierval (closed French residential) — to individual savers, institutional investors, wealth management professionals, and healthcare facility operators.
Is Euryale a public or private company?
Euryale is a private company. It is classified as corporate owned and is currently operating.
When was Euryale founded?
Euryale was founded in 2010. It employs 51 to 100 people.
Where is Euryale based?
Euryale is headquartered in Not specified, France, in the Europe region.
How does Euryale make money?
One revenue line is on record: SCPI Asset Management Fees.
Who are Euryale's main competitors?
Direct peers on record are Sofidy, Perial Asset Management, Primonial REIM, Paref Gestion and Inter Gestion REIM. Broad incumbents are AXA IM Alts, Welltower Inc., Swiss Life Asset Managers (Healthcare) and Medical Properties Trust. Alderan is listed as an emerging player.
Does Euryale have an API?
No public API is recorded for Euryale.
What industry is Euryale in?
Euryale's product category is Healthcare Real Estate Asset Management. Its primary akta.pro industry code is BPAJABAH, Special Purpose & Alternative Asset Brokerage, with a secondary code of FSAAADAC, Family Office Advisory & Outsourced CIO (OCIO). Its NAICS code is 523940 and its SIC code is 6282.